Attached Segments and Cryovial Samples as a Useful Tool in Cord Blood Banking Quality Control

Background: Assessment of the umbilical cord blood (UCB) unit is a crucial issue in the hematopoietic stem cell transplantation. A cord blood bank (CBB) must ensure that the final product of transplantation is represented accurately from quality control (QC) products of the UCB unit. The use of a tube segment attached to the UCB unit as well as a separate 1.8 mL cryovial containing an identical aliquot of the cryopreserved UCB unit product was exposed to the same post-processing freezing and storage conditions as the UCB unit. Eventually, the utility of the attached segment and the 1.8 mL cryovial was evaluated as valid QC tools in order the final UCB unit graft to be validated. Methods: A total of 30 cord blood (CB) units, stored in liquid nitrogen, with their attached segments and 1.8 mL cryovials were thawed and several QC parameters (total nucleated cells (TNCs), CD34 + cells, CD133 + cells, percent viability and recovery) were obtained. Functional tests such as clonogenic assays were also performed. Results: Non-statistical differences were observed between UCB units, attached segments and 1.8 mL cryovials for any of the examined parameters. The expected clonogenic efficiency (ECLONE) was above 80% for all the three kinds of thawed samples (UCB unit, attached segment and QC sample). Conclusions: The QC of attached segment and 1.8 mL cryovial linked to the cryopreserved UCB unit may be used as a means to predict the potency and functionality of the actual UCB unit before transplantation. J Hematol. 2015;4(1):125-130 doi: http://dx.doi.org/10.14740/jh198w

[1]  L. Notarangelo,et al.  Cord Blood Banking for Potential Future Transplantation , 2017, Pediatrics.

[2]  B. Kim,et al.  Attached Segment has Higher CD34+ Cells and CFU-GM than the Main Bag after Thawing , 2015, Cell transplantation.

[3]  H. Broxmeyer,et al.  Cord Blood Hematopoietic Cell Transplantation , 2010 .

[4]  H. Broxmeyer Cord blood hematopoietic stem cell transplantation ∗ , 2010 .

[5]  K. Ballen,et al.  Collection and preservation of cord blood for personal use. , 2008, Biology of Blood and Marrow Transplantation.

[6]  N. Greco,et al.  Assessment of cord blood hematopoietic cell parameters before and after cryopreservation , 2007, Transfusion.

[7]  J. V. van Burik,et al.  Infectious complications following unrelated cord blood transplantation , 2007, Vox sanguinis.

[8]  M. Duval,et al.  Assessment of cord blood unit characteristics on the day of transplant: comparison with data issued by cord blood banks , 2006, Transfusion.

[9]  Luciano Rodríguez,et al.  Predictive utility of the attached segment in the quality control of a cord blood graft. , 2005, Biology of blood and marrow transplantation : journal of the American Society for Blood and Marrow Transplantation.

[10]  D. Planelles,et al.  Utility of bag segment and cryovial samples for quality control and confirmatory HLA typing in umbilical cord blood banking. , 2004, Clinical and laboratory haematology.

[11]  A. Nagler,et al.  Umbilical cord blood transplantation--how, when and for whom? , 2004, Blood reviews.

[12]  D. Macleod,et al.  Infectious Complications , 2003, Regional Anesthesia & Pain Medicine.

[13]  D. Regan,et al.  Long term cryostorage of UC blood units: ability of the integral segment to confirm both identity and hematopoietic potential. , 2003, Cytotherapy.

[14]  J Wagner,et al.  Transplantation of unrelated donor umbilical cord blood in 102 patients with malignant and nonmalignant diseases: influence of CD34 cell dose and HLA disparity on treatment-related mortality and survival. , 2002, Blood.

[15]  J. Liesveld,et al.  Impact of mobilized blood progenitor cell quality determined by the CFU-GM/CD34+ ratio on rapid engraftment after blood stem cell transplantation. , 2002, Blood cells, molecules & diseases.

[16]  E. Gluckman Current status of umbilical cord blood hematopoietic stem cell transplantation. , 2000, Experimental hematology.

[17]  J. Adamson,et al.  CLINICAL OBSERVATIONS, INTERVENTIONS, AND THERAPEUTIC only. TRIALS , 2022 .

[18]  J. Adamson,et al.  Outcomes among 562 recipients of placental-blood transplants from unrelated donors. , 1998, The New England journal of medicine.

[19]  J. Adamson,et al.  Processing and cryopreservation of placental/umbilical cord blood for unrelated bone marrow reconstitution. , 1995, Proceedings of the National Academy of Sciences of the United States of America.